proteome sciences plc on monday said it expects to report higher revenue and earnings for 2022 despite higher costs and that it is strongly positioned for 2023 the proteinbiomarker research company said that for the year to dec 31 it sees revenue increase to 78 million pounds 94 million from gbp51 million in the previous year earnings before interest taxes depreciation and appreciation are estimated to come in at gbp20 million from gbp600000 it said its operating costs are expected to be gbp59 million from gbp47 million due to higher investment in staffing equipment and price rises at dec 31 cash reserves stood at gbp40 million it said the group said it has over gbp11 million in purchase orders carried forward into 2023 the improved cash position at the end of 2022 provides a good starting point for the new year and when combined with the investment we have made and a significant order book being carried forward our business is strongly positioned for 2023 said chief executive mariola soehngen